[{"id":"e61adf06-d406-45f5-8f21-d7a2cfb82fb1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05445765","created_at":"2022-07-06T15:54:41.802Z","updated_at":"2024-07-02T16:36:07.720Z","phase":"Phase 1","brief_title":"Anti-CD33 CAR-T Cells for the Treatment of Relapsed/Refractory CD33+ Acute Myeloid Leukemia","source_id_and_acronym":"NCT05445765","lead_sponsor":"iCell Gene Therapeutics","biomarkers":" CD33","pipe":" | ","alterations":" CD33 positive","tags":["CD33"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD33 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ICG165"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 07/01/2022","start_date":" 07/01/2022","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 06/30/2024","study_completion_date":" 06/30/2024","last_update_posted":"2022-07-06"}]